Search the Newsreel

Kyivstar Group Ltd. Revenue Breakdown – NASDAQ:KYIV

This article provides a basic overview of Kyivstar Group Ltd. (NASDAQ: KYIV) financials, including access to statements, statistics, dividends, earnings, and segment performance. It highlights information available through TradingView, emphasizing revenue breakdown by source and country.

TVS Motor Company Limited Revenue Breakdown – NSE:TVSMOTOR

VSE Corporation Revenue Breakdown – NASDAQ:VSEC

Versus Systems Inc (VS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Versus Systems Inc (VS), outlining its major shareholders and institutional holdings. It shows that ASPIS Cyber Technologies, Inc. and Cronus Equity Capital Group, LLC are the largest shareholders, holding 43.97% and 20.20% respectively. The report also provides …

CVS Group plc Revenue Breakdown – LSE:CVSG

Versus Systems Inc (VS) Institutional Confidence

This article provides details on the institutional confidence score for Versus Systems Inc (VS), which currently stands at 3.00, with no recent change. It lists key institutional shareholders and their shareholdings, including ASPIS Cyber Technologies, Inc., Cronus Equity Capital Group, LLC, and Citadel Advisors …

VSE Corporation (VS3) Q3 2025 Earnings Report - Results, Call & Slides

VSE Corporation (VS3) announced its Q3 2025 earnings, reporting actual EPS of €0.87, beating the consensus of €0.74 by €0.13, and actual revenue of €248.48M, surpassing the expected €242.77M by €5.71M. The company also saw a 3.40% year-over-year revenue growth. The next earnings date …

Notícias CVS Health Corporation - CVS | Ações New York Stock Exchange | ADVFN Brasil

Vsee Health Inc (VSEE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Vsee Health Inc (VSEE), listing its major individual and institutional holders. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activities including changes in holdings for key investors. The stock currently …

Price to sales forward of Kyivstar Group Ltd. – NASDAQ:KYIVW

This article provides a brief financial overview of Kyivstar Group Ltd. (NASDAQ: KYIVW), specifically focusing on its forward price-to-sales ratio. The content appears to be a stub or a section of a larger financial data platform, showing basic financial information and market status for …

CVS Health Corp (CVS) Valuation: PE, PB & Fair Value Analysis

This article provides an analysis of CVS Health Corp's (CVS) valuation, noting its current valuation score of 8.27 and its ranking within the Healthcare Providers & Services industry. It highlights the current P/E ratio, comparing it to recent highs and lows, while also mentioning …

VSE Corp (VSEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a detailed revenue breakdown for VSE Corp (VSEC), categorized by business segments and geographical regions. It shows that Product sales account for 63.29% of revenue and Service sales for 36.71%. The United States is the primary revenue source, contributing 56.61%, followed …

VSE Corp (VSEC) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for VSE Corp (VSEC), detailing its volatility, financial risk, and investment risk. VSEC has a risk assessment score of 6.81, ranking it 23rd out of 72 in the Aerospace & Defense industry. The company's beta value of 1.43 …

VSE Corp (VSEC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of VSE Corp (VSEC), highlighting its current valuation score, P/E ratio, and industry ranking. It notes that key P/B, P/S, and P/CF data have not been disclosed by the company. The analysis positions VSE Corp within the Aerospace …

Vsee Health Inc (VSEE) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Vsee Health Inc (VSEE), assigning it a current financial score of 5.49, which ranks it 461 out of 485 in the Software & IT Services industry, indicating a weak financial status and low operating efficiency. The report …

VSEE|Vsee Health Inc|Price:0.079|Chg%:-0.002

Vsee Health Inc (VSEE) is trading at $0.079, down 2.59%. The company operates through VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc., providing a no-code/low-code SaaS telehealth platform and acute care telehealth services. Key executives and shareholder information, including institutional holdings, are detailed.

Versus Systems forecasts June 30, 2026 total assets at $4.14 million in pro forma outlook

Versus Systems forecasts total assets of $4.14 million by June 30, 2026, a significant increase from $1.66 million on March 31, 2026. This projection includes $1.36 million in cash from stock sales and $1.42 million in accounts receivable from a renewed technology license agreement. …

VSE Corp (VSEC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a detailed historical timeline of VSE Corp (VSEC) dividends, showing interim and final cash dividends with their respective record, payment, and ex-dividend dates. Over the past five years, VSE Corporation has distributed a total of 22.03 million USD in dividends. The …

VSE Corp (VSEC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of VSE Corp (VSEC), listing major institutional holders like T. Rowe Price and BlackRock. It categorizes shareholder types and provides a quarterly breakdown of institutional shareholdings, indicating changes in the number of institutions and shares held over time. …

CVS HEALTH CORP : UBS RAISES TARGET PRICE TO $122 FROM $115

UBS has increased its target price for CVS Health Corp (CVS.N) to $122 from $115. This news was reported by Reuters. The article highlights an analyst action related to CVS Health Corp's stock.

CVS Health Corp (CVS) - Tradingkey Stock Score & Comprehensive Stock Analysis

This article provides a comprehensive stock analysis of CVS Health Corp (CVS) from TradingKey, highlighting its "Stock Score" which evaluates financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment. CVS shows stable fundamentals with significant growth potential, is considered fairly valued …

VSEC|VSE Corp|Price:195.410|Chg%:-1.940

VSE Corp (VSEC) is trading at $195.410, down 0.98%. The article provides a detailed financial overview of the company, including its income statement, balance sheet, and cash flow statement, based on its FY2025 earnings report. Key figures from FY2025 include a total revenue of …

How Safe Is CVS Health’s Dividend?

Quick Read CVS's $7.8 billion in free cash flow covers its $2.66 annual dividend more than twice, despite 11 consecutive quarters without a raise. A leveraged balance sheet with $175 billion in liabilities and $323 million in recent insider selling are the key risks …

Versus Systems (NASDAQ: VS) lifts equity above Nasdaq $2.5M minimum

Versus Systems Inc. has raised its stockholders' equity above the Nasdaq minimum requirement of $2.5 million, addressing a deficiency letter. This was achieved through a stock purchase agreement with ASPIS Cyber Technologies, generating $1.7 million, and renewed licensing agreements that recognized $1.485 million in …

Versus Systems regains Nasdaq equity compliance after $1.7M stock sale and $1.485M license revenue

Versus Systems (VS) has regained compliance with Nasdaq's $2.5 million stockholders' equity requirement. This was achieved through the issuance of 1,310,969 common shares for $1.7 million and the recognition of $1.485 million in license revenue in Q2 2026. The company's pro forma stockholders' equity …

CVS Health (CVS) Faces Henry Ford Health Lawsuit Over $29 Million 340B Claims

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Henry Ford Health has filed a lawsuit against CVS Health (NYSE:CVS) alleging fraudulent reimbursement practices tied to the federal 340B drug discount program. The complaint …

CVS Health (CVS) Stock Sees Modest Fair Value Lift As Analysts Raise Targets

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. CVS Health is in focus after a modest reset to its price target framework, with the updated intrinsic value estimate moving from US$107.73 to …

Enterprise value to EBIT forward of Kyivstar Group Ltd. – NASDAQ:KYIVW

This article presents financial data for Kyivstar Group Ltd. (NASDAQ:KYIVW), specifically focusing on its enterprise value to EBIT forward. The information is provided by TradingView, with market data from ICE Data Services and reference data from FactSet. The content is primarily a data page …

VSEC|VSE Corp|Price:196.560|Chg%:-0.790

VSE Corp (VSEC) shows strong fundamentals with high growth potential and is considered fairly valued in the Aerospace & Defense industry. Analysts widely rate the stock as "Buy," with a target price of $250.158, despite recent sideways trading. The company specializes in aviation distribution …

CVS Group Q4 Earnings Call Highlights

Key Points Interested in CVS Group plc? Here are five stocks we like better. CVS Group said full-year revenue topped GBP 710 million, up 5.9%, and expects adjusted EBITDA to be in line with consensus with margins broadly flat at about 20%. Net debt …

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this drugstore chain and pharmacy benefits …

First Trust Advisors LP Raises Stake in CVS Health Corporation $CVS

First Trust Advisors LP has increased its holdings in CVS Health Corporation by 4.2% in the first quarter of 2026, now owning 2,344,647 shares valued at $168.39 million. Other institutional investors have also adjusted their stakes, with 80.66% of CVS stock currently held by …

CVS Health Corporation (NYSE:CVS) Receives Average Recommendation of "Moderate Buy" from Analysts

CVS Health Corporation (NYSE:CVS) has received an average "Moderate Buy" rating from analysts, with 21 out of 24 recommending a buy and an average 1-year price target of $105.38. The company recently reported strong quarterly results, exceeding EPS and revenue expectations, and declared a …

CVS Health (NYSE:CVS) Raised to "Buy" at Wall Street Zen

Wall Street Zen upgraded CVS Health (NYSE:CVS) to a "Buy" rating from "Hold," contributing to a generally positive outlook from analysts. The consensus among 21 analysts is a "Moderate Buy" with a target price of $105.38. Despite the upgrade, CVS shares were down 2.4% …

VSE to report second-quarter 2026 results after Aug. 5 close

VSE Corporation (NASDAQ: VSEC, VSECU) announced it will release its second-quarter 2026 financial results after the market closes on Wednesday, August 5, 2026. The company will then host a conference call on Thursday, August 6, 2026, at 8:30 AM ET to discuss the results, …

VSE Corp (VSEC) director transfers 133 shares to revocable trust

VSE Corp director Mark E. Ferguson III transferred 133 shares of common stock to the Mark E. Ferguson III Revocable Trust via a bona fide gift on July 20, 2026, receiving no consideration. This transaction, reported under a Rule 10b5-1 trading arrangement, resulted in …